comparemela.com

Latest Breaking News On - Medpage today - Page 13 : comparemela.com

Triplet Notches Survival Win in Heavily Pretreated DLBCL

Benefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant

United statesCheju doSouth koreaKim ja brentuximabAmerican society of clinical oncologyCatholic university of koreaJeonga kimCatholic universityAmerican societyClinical oncologyManaging editorMedpage today

Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer

Trastuzumab deruxtecan extended its superiority versus chemotherapy into HER2-ultralow

United statesJulie gralowGiuseppe curiglianoCharles bankheadErica mayerAmerican society of clinical oncologyEuropean institute of oncologyUniversity of milanEuropean instituteAmerican societyClinical oncologyDana farber cancerMedpage today

Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trial

Better efficacy with brentuximab vedotin versus standard chemo, substantially less toxicity

United statesDana farber cancer institutePeter borchmannCharles bankheadJulie gralowOreofeo odejideUniversity hospital of cologneGerman hodgkin study groupAmerican society of clinical oncologyUniversity hospitalAmerican societyClinical oncologyMedpage today

How Have Kids Colorectal Cancer Rates Changed?

You passed medical training, now see if you can pass our weekly quiz

Medpage today

Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agents

China-based trial may present a hurdle to FDA approval, however

United statesGrupo oncoclZhang li ivonescimabWilliam jrPpamerican society of clinical oncologyNational comprehensive cancer networkAmerican society of clinical oncologyClinical oncologyNorth americaManaging editorMedpage todayStudy investigators

vimarsana © 2020. All Rights Reserved.